Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma
Authors:
- Takeshi HisadaTHTakeshi Hisada
- Tamotsu IshizukaTITamotsu Ishizuka
- Mitsuyoshi UtsugiMUMitsuyoshi Utsugi
- Tadayoshi KawataTKTadayoshi Kawata
- Yasuo ShimizuYSYasuo Shimizu
- Fumikazu OkajimaFOFumikazu Okajima
- Kunio DobashiKDKunio Dobashi
- Masatomo MoriMMMasatomo Mori
- 1 March 2008
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 367 (2) , 509-515
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Transcription factors in airway diseasesLaboratory Investigation, 2006
- Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammationJournal of Allergy and Clinical Immunology, 2006
- Protective Effect of Fish Oil Supplementation on Exercise-Induced Bronchoconstriction in AsthmaChest, 2006
- Dampening inflammationNature Immunology, 2005
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1Journal of Experimental Medicine, 2005
- Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial CellsJournal of Biological Chemistry, 2003
- Points of control in inflammationNature, 2002
- ResolvinsJournal of Experimental Medicine, 2002
- AsthmaNew England Journal of Medicine, 2001